NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric

A rubric for evaluating the FAIRness of NIH-CFDE Resources

Tags: nihcommonfund

URL(s):

View Associations

Rubric Assessments (626384)


Assessment Metrics Date
Target Project   Contact information is provided for the creator(s) of the dataset. Globally unique identifier Machine-readable metadata Standardized metadata Resource identifier in metadata Open, Free, Standardized Access protocol Digital resource license Metadata license NIH program name is available for querying NIH project name is available for querying The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology A landing page exists and is accessible
ACSL5 Whole Body Bile Acids Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Whole unconditioned medium (Defined culture media, M199),Whole M1 medium,Whole M2 medium Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
H3K27M cells and glutamine metabolomics 1 million cell test (part-I) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 23, 2019
High Resolution GC-MS and FID Metabolomics of Human Serum Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
CHEAR Pooled Plasma Reference Material Proficiency Test Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 23, 2019
Targeted NEFA in Kallikrein 6 Mice after SCI Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 23, 2019
Investigating ceremide concentrations in mice muscle tissue lacking insulin receptors and IGF-1 receptors Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabotypes of Subjects with Adverse Reactions Following Vaccination Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolomics Approach to Identify Molecules and Pathways Involved in the Development of Atherosclerotic Coronary Artery Disease Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Analysis the concentration of betaine, choline, TMA, TMAO and amino acids in plasma in Megalobrama amblycephala. Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Global NHP serum metabolomics (part-IV) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
E.coli effects on growth and substrate uptake of green algae (part I - HILIC) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glucose exposures Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Characterization of metabolomics profile changes during development of post-traumatic epilepsy in Rat Plasma (part-I) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 23, 2019
Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Statin Immuno-Metabolomics in Asthma (part II) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
2HG concentration in human IDH1m cells Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Glycolysis/TCA/Nucleotide_Wt_KO_TimeCourse_LPS Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolic Microenvironments in Normal Breast and Breast Cancer (MS analysis) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
NIST SRM Smoker non-Smoker Urine Comparison Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolite signatures in trauma patients with venous thromboembolism (VTE) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Mouse skeletal myotube chronic low-frequency stimulation Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Biomarker Discovery in Knee Osteoarthritis (II) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Liver and Plasma metaboites for 13C-glucose load in wild type, LIRKO GTT 1 mice Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Metabolomics analysis of microbiome gut model (without Lactate) Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2
no (0.00) no (0.00) yes (1.00)   yesbut (0.75) no (0.00) no (0.00) yes (1.00) no (0.00) yes (1.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) no (0.00) Sep 23, 2019